BUILT THE CATALOG.
WORKS THE USE CASE.

Molekul maps Russian pharmacology, original research and unresolved evidence questions. These founder-reported minimum catalog counts describe source records, not independently validated therapies.

Banking and commodity experience inform capital allocation and commercial judgment. Maritime work and personal experiments shaped the questions behind Antaeus. Controlled research will test those hypotheses.

Recruit a development lead or adviser who has taken a molecule through IND work. The pre-seed round funds scientific leadership and qualified laboratory capacity. No scientific appointments or CRO contracts are announced.

Recruit computational capability around source extraction, experiment selection and prospective model benchmarking. The company will judge AI by experimental performance rather than branding.